Activity 1

Development and optimization of innovative techniques and methods that allow the assurance of post-marketing quality of medicines used by the population for the treatment and prevention of AIDS and NTD, according to international standards.

Activity 1.1.

Identification and selection of drugs to control.

Activity 1.2.

Design, optimization and validation of a methodology for the analysis of selected drugs.

Activity 1.3.

Development of tests and assays for the establishment of pharmaceutical equivalents.

Activity 2

Design of sampling plans at the critical points of distribution and dispensing of medicines and surveillance studies that allow the evaluation of the health risk involved in the consumption of substandard drugs.

Activity 2.1.

Design of a sampling plan for the monitoring of selected medications.

Activity 2.2.

Collection and transport of samples.

Activity 3

Transfer of the results obtained in R&D to support the WHO prequalification for the LNCQM.

Activity 3.1.

Qualification of personnel specialized in the analysis and control of medicines in accordance with international quality and safety regulations.

Activity 3.2.

Implementation of a basic control methodology in the LNCQM.